IGM Biosciences, Inc. (41) | Business Operations (2)
- Collaboration and License Agreement by and between IGM Biosciences, Inc. and Genzyme Corporation, dated March 28, 2022 (Filed With SEC on March 29, 2022)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on September 3, 2019)